Mangoceuticals Inc. - Utang jangka cendhak perusahaan MGRX

Mangoceuticals, Inc. (MGRX) has created a high-demand service for men, where privacy and the accessibility of prescription medications ensure customer loyalty. The business relies on a DTC model, offering wellness products via a digital platform. The dynamics of the company's short-term debt demonstrate current liquidity, with the parameter stabilizing at 0.00. Market share growth is supported by intensive promotion without the execution of merger deals.

MGRX: Utang jangka cendhak MangoRx 28.04.2023 - 29.10.2026

Ringkesan rincian data analitis Mangoceuticals Inc. (MGRX)

- rega lan prakiraan konsensus rega:

Rega saham MangoRx|MGRX - Rata-rata rega prakiraan

- data kapitalisasi pasar:

Nilai pasar Mangoceuticals, Inc.|MGRX - Rega Nyata Tumbas Perusahaan Kanthi Wutuh

- data kapitalisasi buku:

Nilai Buku saben Saham Mangoceuticals|MGRX - Ekuitas Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku mangorx.com|MGRX - Total Aset Bisnis

- data utang lan likuiditas:

Utang marang Ekuitas Mangoceuticals, Inc.|MGRX - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal MangoRx|MGRX - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Mangoceuticals, Inc.|MGRX - Tanggungan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Mangoceuticals

Pambiji fundamental perusahaan:Mangoceuticals, Inc.

For Mangoceuticals, Inc. (MGRX), whose digital telemedicine model and drug logistics rely on external partnerships, monitoring liabilities of up to one year is critical for assessing the sustainability of the operating cycle. Analyzing the company's current liabilities allows for the identification of liquidity shortage risks by comparing accounts payable repayment rates with incoming cash flow to confirm high asset quality.

Pesaing Mangoceuticals, Inc. (MGRX)